No image set

Rheumatic Learning: How Can You Help Jeff With His Psoriatic Arthritis?

Array

Activity Info

Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are related disorders with distinct features. Participate in this case focused on Jeff who has psoriatic arthritis.

Email

 


Activity Title


Rheumatic Learning: How Can You Help Jeff With His Psoriatic Arthritis?


Topic


Rheumatology


Release Date


September 30, 2020


Expiration Date


September 29, 2021


Estimated Time to Complete Activity


0.50 hour

 

Program Description   

Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are related disorders with distinct features. While there are underlying similarities between the 2 disorders, the immune processes and pathways differ slightly, which is important with regard to choice of appropriate therapies. Given the increased need for PAs and NPs to enter the shrinking rheumatology field (anticipated to shrink by one-quarter by 2030), the complex pathways associated with immunology and pathophysiology, the number of available agents to treat these disorders, and challenges associated with clinical decision-making, it is critical that PA/NPs be provided with more education on these disorders and their management. This activity includes patient videos, animations, and interactive elements for quick review by busy PAs and NPs.

Intended Audience:  Physician Assistants and Nurse Pracitioners

COMMERCIAL SUPPORT ACKNOWLEDGMENT
This program is supported by an independent education grant funded by Pfizer.

LEARNING OBJECTIVE
Upon completion of the activity, participants should be able to:

    • 1. Describe inflammatory pathways and how they contribute to the pathophysiology of RA and PsA
    • 2. Choose appropriate therapy to manage the patient with RA and PsA

 
ACCREDITED PROVIDER

This activity is provided by American Academy of Physician Assistants in collaboration with The France Foundation

Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, or other members at the The American Academy of Physician Assistants who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

DISCLOSURE POLICY
In accordance with the ACCME Standards for Commercial Support, the American Academy of Physician Assistants (AAPA) and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AAPA and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AAPA and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AAPA and TFF are committed to providing learners with high-quality CME.

DISCLOSURE OF UNLABELED USE
AAPA and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AAPA and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer: The opinions and comments expressed by faculty and other experts, whose input is included in this activity, are their own. This activity is produced for educational purposes only. Please review complete prescribing information of specific drugs mentioned in this program including indications, contraindications, warnings, and adverse effects and dosage before administering to patients.

 

FACULTY

Kori Dewing, DNP, ARNP, ANP-BC
Rheumatology Nurse Practitioner
University of Washington School of Nursing
Affiliate Assistant Professor

Benjamin J. Smith, DMSc, PA-C, DFAAPA
Director of Didactic Education, Assistant Professor
School of Physician Assistant Practice
Florida State University College of Medicine

 

The following faculty report that they have no relevant financial relationships to disclose:

  • Kori Dewing, DNP, ARNP, ANP-BC
  • Benjamin J. Smith, DMSc, PA-C, DFAAPA

 

COPYRIGHT INFORMATION
Copyright © 2020 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

    • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
    • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.

PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy-policy.

 
CONTACT INFORMATION
If you have questions about this activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com

CLICK HERE TO VIEW TECHNICAL REQUIREMENTS

 

Search